A $3bn boost for COVID therapeutic development in the Biden Administration’s American Rescue Plan is a tiny piece of the enormous $1.9tn recovery package, but the discussions that the funding will trigger about FDA’s performance in the pandemic response could have implications beyond the size of the investment.
The therapeutics funding is small even compared to just the public health commitments in the new President’s proposed COVID relief...